96 related articles for article (PubMed ID: 2513217)
1. Differentiation-linked expression of the plasminogen activator inhibitor type-2 gene in the human HL-60 promyelocytic cell line.
Arndt AD; Gohill J; Rankin K; Houwen B; Hart DA
Exp Cell Res; 1989 Dec; 185(2):473-81. PubMed ID: 2513217
[TBL] [Abstract][Full Text] [Related]
2. Induction of plasminogen activator inhibitor type 2 expression during differentiation of human K562 cells towards a macrophage phenotype.
Rehemtulla A; Arndt A; Hart DA
Biochem Cell Biol; 1990 Dec; 68(12):1337-43. PubMed ID: 1964793
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone and phorbol ester, but not cytokines, increase the production of plasminogen activator inhibitor type-2 in the PL-21 human promyelocytic leukemia cell line.
Niiya K; Takeuchi T; Kobayashi M; Miyoshi I; Hayashi T; Sakuragawa N
Thromb Haemost; 1991 Aug; 66(2):232-8. PubMed ID: 1771617
[TBL] [Abstract][Full Text] [Related]
4. Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells.
Antalis TM; Dickinson JL
Eur J Biochem; 1992 Apr; 205(1):203-9. PubMed ID: 1555580
[TBL] [Abstract][Full Text] [Related]
5. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes.
Mollinedo F; Gajate C; Tugores A; Flores I; Naranjo JR
Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):137-44. PubMed ID: 8363564
[TBL] [Abstract][Full Text] [Related]
6. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
7. The role of the c-fms oncogene in the regulation of HL-60 cell differentiation.
Wu J; Zhu JQ; Han KK; Zhu DX
Oncogene; 1990 Jun; 5(6):873-7. PubMed ID: 2141686
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
Schuster WA; Medcalf RL; Kruithof EK
Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor type 1: cell-specific and differentiation-induced expression and regulation in human cell lines, as determined by enzyme-linked immunosorbent assay.
Lund LR; Georg B; Nielsen LS; Mayer M; Danø K; Andreasen PA
Mol Cell Endocrinol; 1988 Nov; 60(1):43-53. PubMed ID: 3265112
[TBL] [Abstract][Full Text] [Related]
10. Activation of interleukin-1 beta gene expression during retinoic acid-induced granulocytic differentiation of promyeloid leukemia cells.
Matikainen S; Tapiovaara H; Vaheri A; Hurme M
Cell Growth Differ; 1994 Sep; 5(9):975-82. PubMed ID: 7819135
[TBL] [Abstract][Full Text] [Related]
11. Effects of simultaneous and sequential exposure to granulocytic and monocytic inducers on the choice of differentiation pathway in HL-60 promyelocytic leukemia cells.
Zinzar S; Ohnuma T; Holland JF
Leuk Res; 1989; 13(1):23-30. PubMed ID: 2915572
[TBL] [Abstract][Full Text] [Related]
12. [Production and secretion of the plasminogen activator inhibitor type-2 in a leukemia cell line].
Niiya K
Rinsho Ketsueki; 1991 May; 32(5):490-6. PubMed ID: 1870266
[TBL] [Abstract][Full Text] [Related]
13. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
14. Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21.
Niiya K; Taniguchi T; Shinbo M; Ishikawa T; Tazawa S; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1994 Jul; 72(1):92-7. PubMed ID: 7974383
[TBL] [Abstract][Full Text] [Related]
15. Activation of plasminogen activator inhibitor-1 synthesis by phorbol esters in human promyelocyte HL-60--roles of PCKbeta and MAPK p42.
Lopez S; Peiretti F; Morange P; Laouar A; Fossat C; Bonardo B; Huberman E; Juhan-Vague I; Nalbone G
Thromb Haemost; 1999 Mar; 81(3):415-22. PubMed ID: 10102471
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone modifies the functional responses of the granulocytic differentiating HL-60 cells.
Collado-Escobar D; Mollinedo F
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):553-9. PubMed ID: 7909661
[TBL] [Abstract][Full Text] [Related]
17. Relationship of calcitonin mRNA expression to the differentiation state of HL 60 cells.
Kiefer P; Bacher M; Pflüger KH
Leuk Lymphoma; 1994 May; 13(5-6):501-7. PubMed ID: 7520792
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C beta gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol ester-induced differentiation.
Tonetti DA; Horio M; Collart FR; Huberman E
Cell Growth Differ; 1992 Oct; 3(10):739-45. PubMed ID: 1445803
[TBL] [Abstract][Full Text] [Related]
19. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53.
Jiang H; Lin J; Su ZZ; Collart FR; Huberman E; Fisher PB
Oncogene; 1994 Nov; 9(11):3397-406. PubMed ID: 7936668
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3 and phorbol myristate acetate produce divergent phenotypes in a monomyelocytic cell line.
Biskobing DM; Rubin J
Endocrinology; 1993 Feb; 132(2):862-6. PubMed ID: 8425498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
